Patients with COVID-19 will be given the cystic fibrosis drug 鈥楧ornase alfa鈥� to determine if it can help improve survival by reducing excess inflammation in the lungs, as part of a trial co-led by UCL and the Francis Crick Institute.
, More: 皇家华人ews
Close
